Respiratory Inhalers Market Overview:

Industrialization, air pollution and smoking has resulted in an indefinite increase in environmental pollution thereby giving birth to different respiratory ailments such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. The global respiratory inhalers market is on high pace owing to rapid increase in respiratory diseases. Respiratory inhalers have been created to counter such respiratory disorders. They are medical devices which are used for helping patients experiencing breathing problems occurring from respiratory disorders such as ARDS (acute respiratory distress syndrome), COPD, asthma and fibrosis.

There are key drivers that is driving the growth of the respiratory inhalers market. Some of the market trends and factors in this market as per an analysis conducted by Market Research Future (MRFR) include unhealthy lifestyle, increase in pollution, rising use of combination therapies owing to associated perks such as increased efficacy and easy reimbursement policies.  However, there are some restraints that is restricting the growth of the respiratory inhalers market such as complications and side effects during inhalation, lack of accuracy and increasing prices of devices. The global respiratory inhalers market is anticipated to grow at a splendid 6.1% CAGR during the assessment period (2017-2023).

Major key Players:

• Teva Pharmaceutical Industries Ltd.
• AstraZeneca
• PARI Medical Holding
• Beximco Pharmaceuticals Ltd.
• OMRON Healthcare Europe
• Boehringer Ingelheim GmbH
• Merck Co Inc.
• GlaxoSmithKline plc
• Cipla Ltd.
• Koninklijke Philips N.V

Respiratory Inhalers Market Geographical Analysis:

The asthma inhaler devices market has its reach across various verticals of the globe. Over the years it has successfully established its dominance in various regions like Americas, Asia Pacific, Europe and Rest of the World.

Americas has the upper hand out of all the above-mentioned regions. It accounts for the maximum market shares. Its lead can be mainly attributed to a recent survey that suggested that nearly 7.8% of the population was struggling with asthma in US alone. Furthermore, this market will observe expansion due to the presence of major market players and higher investments in the healthcare sector.

Segmentation:

The global market report on the respiratory inhalers can be analyzed on the basis of segments like type, product, application, and end user. This would help in getting insights from the market, which can impact the development of strategies. 

• By type, the global market on the respiratory inhalers can be segmented on the basis of manually-operated and digitally-operated. The manually-operated segment has the largest market share. 
• By product, the global report includes metered dose inhaler, dry powder inhaler, smart inhalers and others. The dry powder inhaler segment is ruling the segment. The metered dose inhaler segment is gaining substantial popularity owing to the fact that it ensures a reliable amount of the dose. It is also known as MDI. Dry powder inhaler has an advantage that it helps the medicine to reach the lungs directly. This is possible due to the powder content, which is easier to inhale. 
• By application, the report comprises segments like asthma, COPD, and others. The asthma segment has the largest market share. 
• By end user, the report on the respiratory inhalers market includes respiratory care center, hospitals clinics, and others. The hospitals clinics segment would dominate the global market. 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited), 

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: info@marketresearchfuture.com